Literature DB >> 16403449

Analysis of the human MutLalpha.MutSalpha complex.

Guido Plotz1, Albrecht Piiper, Marc Wormek, Stefan Zeuzem, Jochen Raedle.   

Abstract

Human DNA mismatch repair is initiated by MutSalpha which ATP-dependently recruits MutLalpha. Analysis of this complex is difficult due to its transient and dynamic nature. We have optimized conditions for investigation of MutLalpha.MutSalpha complexes using a DNA pulldown assay. Non-specific DNA end-binding, which frequently interfered with analysis of the interaction, did not occur under the applied conditions. MutSalpha had significantly higher affinity to DNA mispairs, but its interaction with MutLalpha did not require a mismatch. Complex formation was best supported by low magnesium concentration and low temperature at physiological pH and salt concentration. Complex formation was delayed by the slowly hydrolyzable ATP analog ATPgammaS, undetectable with the non-hydrolyzable analog AMP-PNP, and occurred weakly with a combination of AMP-PNP and ADP, confirming that hydrolysis was required. The described conditions likely capture an intermediate of the repair reaction which has bound ATP and ADP in the two nucleotide-binding sites of MutSalpha.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16403449     DOI: 10.1016/j.bbrc.2005.12.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  DNA mismatch repair and Lynch syndrome.

Authors:  Guido Plotz; Stefan Zeuzem; Jochen Raedle
Journal:  J Mol Histol       Date:  2006-07-04       Impact factor: 2.611

2.  Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential.

Authors:  Mar Giner-Calabuig; Seila De Leon; Julian Wang; Tara D Fehlmann; Chinedu Ukaegbu; Joanna Gibson; Miren Alustiza-Fernandez; Maria-Dolores Pico; Cristina Alenda; Maite Herraiz; Marta Carrillo-Palau; Inmaculada Salces; Josep Reyes; Silvia P Ortega; Antònia Obrador-Hevia; Michael Cecchini; Sapna Syngal; Elena Stoffel; Nathan A Ellis; Joann Sweasy; Rodrigo Jover; Xavier Llor; Rosa M Xicola
Journal:  Br J Cancer       Date:  2022-02-23       Impact factor: 9.075

Review 3.  DNA mismatch repair: molecular mechanism, cancer, and ageing.

Authors:  Peggy Hsieh; Kazuhiko Yamane
Journal:  Mech Ageing Dev       Date:  2008-03-04       Impact factor: 5.432

Review 4.  Platinum Complexes in Colorectal Cancer and Other Solid Tumors.

Authors:  Beate Köberle; Sarah Schoch
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

5.  C-terminal fluorescent labeling impairs functionality of DNA mismatch repair proteins.

Authors:  Angela Brieger; Guido Plotz; Inga Hinrichsen; Sandra Passmann; Ronja Adam; Stefan Zeuzem
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

6.  Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair.

Authors:  Guido Plotz; Christoph Welsch; Luis Giron-Monzon; Peter Friedhoff; Mario Albrecht; Albrecht Piiper; Ricardo M Biondi; Thomas Lengauer; Stefan Zeuzem; Jochen Raedle
Journal:  Nucleic Acids Res       Date:  2006-11-28       Impact factor: 16.971

Review 7.  Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review.

Authors:  Agata Dylawerska; Wojciech Barczak; Anna Wegner; Wojciech Golusinski; Wiktoria Maria Suchorska
Journal:  Med Oncol       Date:  2017-11-15       Impact factor: 3.064

8.  Adenosine triphosphate stimulates Aquifex aeolicus MutL endonuclease activity.

Authors:  Jerome Mauris; Thomas C Evans
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

9.  Low expression of MSH2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma.

Authors:  Camila Santos Pereira; Marcos Vinícius Macedo de Oliveira; Lucas Oliveira Barros; Gabriela Alencar Bandeira; Sérgio Henrique Sousa Santos; John R Basile; André Luiz Sena Guimarães; Alfredo Maurício Batista De Paula
Journal:  J Appl Oral Sci       Date:  2013 Sep-Oct       Impact factor: 2.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.